ReviewBrain sciences2025
Neuroimaging and Machine Learning in OCD: Advances in Diagnostic and Therapeutic Insights.
Review in Brain sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND/
objectivesObsessive-Compulsive Disorder (OCD) is a chronic mental health condition characterized by intrusive thoughts and repetitive behaviors. Traditional diagnostic methods rely on subjective clinical assessments, delaying effective intervention. This review examines how advanced neuroimaging techniques, such as Magnetic Resonance Imaging (MRI) and Diffusion Tensor Imaging (DTI), integrated with machine learning (ML), can improve OCD diagnostics by identifying structural and functional brain abnormalities, particularly in the cortico-striato-thalamo-cortical (CSTC) circuit.
methodsFindings from studies using MRI and DTI to identify OCD-related neurobiological markers are synthesized. Machine learning algorithms like Convolutional Neural Networks (CNNs) and Support Vector Machines (SVMs) are evaluated for their ability to analyze neuroimaging data. The role of transfer learning in overcoming dataset limitations and heterogeneity is also explored.
resultsML algorithms have achieved diagnostic accuracies exceeding 80%, revealing subtle neurobiological markers linked to OCD. Abnormalities in the CSTC circuit are consistently identified. Transfer learning shows promise in enhancing predictive modeling and enabling personalized treatment strategies, especially in resource-constrained settings.
conclusionsThe integration of neuroimaging and ML represents a transformative approach to OCD diagnostics, offering improved accuracy and biologically informed insights. Future research should focus on optimizing multimodal imaging techniques, increasing data generalizability, and addressing interpretability challenges to enhance clinical applicability. These innovations have the potential to advance precision diagnostics and support more targeted therapeutic interventions, ultimately improving outcomes for individuals with OCD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.